Save 50% of the cost of category C tolterodine 4mg prescriptions by
prescribing Neditol XL.^®2**

By prescribing Neditol^® XL by brand, the average savings for a CCG could still be £15,800 per year, providing the NHS with a total potential annual prescribing cost saving of approximately £2.09 million.^1*

Neditol XL Cost Calculator

To find out how much you could save by prescribing Neditol XL, please follow the instructions on the Neditol XL calculator:

Neditol XL is part of the cost-saving prolonged-release product range from Aspire Pharma.

• 50% saving on cost of Category C Drug Tariff price;^2**
• Additional 2mg XL strength (available for the first time on the UK market);
• High level of stockholdings;
• Price Guarantee^***
• Available from all mainline wholesalers;
• Bioequivalent to the originator.³

References: *Savings based on market data in reference 1. Savings based on market data in reference 1 for 132 Healthboards/CCGs switching their generic and brand originator tolterodine 2mg and 4mg prolonged-release capsules prescriptions to Neditol XL. **Based on 50% saving on the cost of Category C tolterodine prolonged-release tablets in the UK Drug Tariff. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review, regardless of competitor activity. References: 1) epact data Jun21-Aug21 (UK). 2) July 2022 UK drug Tariff. 3) Data on file. 1010067149 v 5.0 September 2021

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148

For more information about Neditol XL, please see the abbreviated prescribing information.

Revision reference – Neditol XL_20_27.07.2022